Fresh analysis indicates that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle programs.
Published data in a prominent health publication demonstrates that while obese people can lose substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these drugs should be cognizant of the danger of fast weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to starting mass in about a year and a half.
Weighing Treatments
The study, which reviewed 37 of studies involving thousands of patients, contrasted the results of these new drugs with older methods.
Researchers emphasize that individuals who shed pounds through dieting typically see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Quick Regain
Nutrition scientists suggest the way of the injections explains the accelerated weight return.
These medications copy a natural hormone called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement means hunger is unsuppressed, making binge eating a significant risk."
An Ongoing Issue?
The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the therapy might need to be long-term.
This opinion is supported by pharmaceutical companies, who state that the results "emphasize the long-term character of excess weight," similar to managing conditions like hypertension.
User Experiences
People who have come off the medication explain a powerful return of cravings.
"It was like a trigger flipping and you're instantly starving," said an individual.
This difficulty is exacerbated if individuals have not adopted permanent dietary or behavioural modifications during therapy.
Growing Adoption
Recent estimates show that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is greater among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while these medications are potent agents for shedding pounds, they are not a standalone fix and long-term success likely depends on combined behavioural changes.
